re he was eventually responsible for global operations of over $145 million of annual revenue. At Omnicare he also oversaw over 800 employees worldwide, and implemented new systems and processes for the company's global drug development operations, including the oversight of all clinical trials, project management, and project profitability. He is a Certified Public Accountant, received his BA from Rutgers University
and his MBA from Pace University
Biography - Dr. Derek Zhang
Dr. Zhang has 10 years of combined experience in the areas of drug research, development and regulatory approval, including four years of industrial experience at Pfizer and six years of regulatory experience at U.S. FDA. Derek was Senior Clinical Pharmacology Reviewer in the Office of Clinical Pharmacology, the Center for Drug Evaluation and Research, the Food and Drug Administration. He successfully reviewed numerous NDAs (including several NME NDAs and BLAs), NDA supplements, and IND submissions. He also contributed to several guidance document development and revision. His specific areas of expertise include clinical pharmacology, biopharmaceutics and regulatory sciences, and he has extensive experience in clinical pharmacology drug development plans/strategies and regulatory requirements. Derek received his Ph.D. from the University of California, San Francisco (UCSF) under Professor Leslie Z. Benet.
About Frontage Laboratories, Inc.
Frontage Laboratories, Inc. is a rapidly expanding global pharmaceutical R&D services company with offices in the U.S., Europe and China. Frontage provides research services to facilitate pharmaceutical discovery, development, preclinical and clinical research, commercialization and product launch, and assists its clients to resolve complex product development issues with a strong, experienced management team. The company's clients include four of the top ten largest
Page: 1 2 3 4 Related biology technology :1
|SOURCE Frontage Laboratories, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR)2
. Codexis Appoints Singapore Laboratories Managing Director3
. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services4
. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision5
. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration6
. Stiefel Laboratories Appoints Two New Members to Board of Directors7
. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg8
. ARUP Laboratories Releases ARUP Consult(R) 2.09
. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression10
. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB11
. Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control